Literature DB >> 21345774

Management of intraoperative fluid balance and blood conservation techniques in adult cardiac surgery.

George Vretzakis1, Athina Kleitsaki, Diamanto Aretha, Menelaos Karanikolas.   

Abstract

Blood transfusions are associated with adverse physiologic effects and increased cost, and therefore reduction of blood product use during surgery is a desirable goal for all patients. Cardiac surgery is a major consumer of donor blood products, especially when cardiopulmonary bypass (CPB) is used, because hematocrit drops precipitously during CPB due to blood loss and blood cell dilution. Advanced age, low preoperative red blood cell volume (preoperative anemia or small body size), preoperative antiplatelet or antithrombotic drugs, complex or re-operative procedures or emergency operations, and patient comorbidities were identified as important transfusion risk indicators in a report recently published by the Society of Cardiovascular Anesthesiologists. This report also identified several pre- and intraoperative interventions that may help reduce blood transfusions, including off-pump procedures, preoperative autologous blood donation, normovolemic hemodilution, and routine cell saver use.A multimodal approach to blood conservation, with high-risk patients receiving all available interventions, may help preserve vital organ perfusion and reduce blood product utilization. In addition, because positive intravenous fluid balance is a significant factor affecting hemodilution during cardiac surgery, especially when CPB is used, strategies aimed at limiting intraoperative fluid balance positiveness may also lead to reduced blood product utilization.This review discusses currently available techniques that can be used intraoperatively in an attempt to avoid or minimize fluid balance positiveness, to preserve the patient's own red blood cells, and to decrease blood product utilization during cardiac surgery.

Entities:  

Mesh:

Year:  2011        PMID: 21345774     DOI: 10.1532/HSF98.2010111

Source DB:  PubMed          Journal:  Heart Surg Forum        ISSN: 1098-3511            Impact factor:   0.676


  6 in total

1.  The Influence of Intraoperative Autotransfusion on Postoperative Hematocrit after Cardiac Surgery: A Cross-Sectional Study.

Authors:  Andrew J Stasko; Alfred H Stammers; Linda B Mongero; Eric A Tesdahl; Samuel Weinstein
Journal:  J Extra Corpor Technol       Date:  2017-12

Review 2.  Cerebral oximetry in cardiac anesthesia.

Authors:  George Vretzakis; Stauroula Georgopoulou; Konstantinos Stamoulis; Georgia Stamatiou; Kosmas Tsakiridis; Paul Zarogoulidis; Nikolaos Katsikogianis; Ioanna Kougioumtzi; Nikolaos Machairiotis; Theodora Tsiouda; Andreas Mpakas; Thomas Beleveslis; Alexander Koletas; Stavros N Siminelakis; Konstantinos Zarogoulidis
Journal:  J Thorac Dis       Date:  2014-03       Impact factor: 2.895

3.  Sizing gaseous emboli using Doppler embolic signal intensity.

Authors:  Caroline Banahan; James P Hague; David H Evans; Rizwan Patel; Kumar V Ramnarine; Emma M L Chung
Journal:  Ultrasound Med Biol       Date:  2012-03-06       Impact factor: 2.998

4.  Conventional hemofiltration during cardiopulmonary bypass increases the serum lactate level in adult cardiac surgery.

Authors:  Rabie Soliman; Eman Fouad; Makhlouf Belghith; Tarek Abdelmageed
Journal:  Ann Card Anaesth       Date:  2016 Jan-Mar

5.  The importance of autologous blood transfusion in lung transplantation and cardiovascular surgeries.

Authors:  Tevfik İlker Akçam; Ali Özdil; Önder Kavurmacı; Pelin Öztürk; Deniz Can Başaran; İsmet Tanzer Çalkavur; Ufuk Çağırıcı; Mustafa Özbaran
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2021-07-26       Impact factor: 0.332

6.  Monitoring of brain oxygen saturation (INVOS) in a protocol to direct blood transfusions during cardiac surgery: a prospective randomized clinical trial.

Authors:  George Vretzakis; Stavroula Georgopoulou; Konstantinos Stamoulis; Vassilios Tassoudis; Dimitrios Mikroulis; Athanasios Giannoukas; Nikolaos Tsilimingas; Menelaos Karanikolas
Journal:  J Cardiothorac Surg       Date:  2013-06-07       Impact factor: 1.637

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.